softraExclusive Early Access to Sofdra – Limited-Time Telehealth Offer!

We’re excited to offer IHhS subscribers exclusive, early access to Sofdra™ (sofpironium) topical gel, a new FDA-approved hyperhidrosis treatment! For one week only, our eligible US community members with commercial insurance* can enjoy:

- $0 Pharmacy Copay for six monthly fills
- Free Home Delivery – no pharmacy trips!
- Exclusive Early Access before it’s available to the public

The only cost to you? $45 for the initial telehealth consultation.

Bonus! Opt to complete all feedback surveys about your experience with the telehealth and pharmacy process, and you’ll receive a $50 gift card!

How to Get Started

🔗 For early access ONLY, schedule your telehealth appointment here
🔗 Want early access AND the $50 gift card? Schedule your telehealth appointment and join the feedback team here

Act Fast – This exclusive early access offer and the chance to earn the gift card will only be available for one week.  The $0 pharmacy copay promotion ends January 31, 2025.

Thank you for helping advance new treatments!

Warmly, 

The International Hyperhidrosis Society Team 


*This offer is exclusively for invited IHhS community members who have commercial insurance. Government insurance, including Medicare, Medicaid, and TriCare, are not accepted for this Program. The independent telehealth service does not accept insurance. Additional offer terms and conditions apply.

Sofdra™ (sofpironium) topical gel, 12.45% is a prescription anticholinergic medicine used on the skin to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children 9 years of age and older.

IMPORTANT SAFETY INFORMATION
Sofdra is for use on the skin in the underarm area only. After applying Sofdra, wash your hands right away and do not touch your underarms. Sofdra is flammable. Avoid heat and flame while applying Sofdra.

Who should not use Sofdra?

Do not use Sofdra if you have certain medical conditions that can be made worse by taking an anticholinergic medicine, such as glaucoma, severe ulcerative colitis (UC) or other serious bowel problems, myasthenia gravis, and Sjogren’s syndrome.

What should I tell my healthcare provider before using Sofdra?

  • Tell your healthcare provider about all of your medical conditions, including prostate, bladder or kidney problems, problems passing urine, if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if Sofdra will harm your unborn baby or pass into your breast milk.
  • Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, especially any anticholinergic medicines.

What are possible side effects of Sofdra?

Serious side effects may include:

  • Urinary retention. Stop using Sofdra and call your healthcare provider right away if you have difficulty urinating, urinate frequently or in a weak stream or drips, a full bladder or difficulty emptying your bladder.
  • Problems with control of your body temperature. Stop using Sofdra and call your healthcare provider right away if you have decreased sweating that develops into symptoms of heat illness (e.g. hot, red skin; passing out; fast, weak pulse; fast, shallow breathing; increased body temperature).
  • Blurred vision. Stop using Sofdra, call your healthcare provider right away, and do not drive or operate machinery or do hazardous work until your vision is clear.

The most common side effects of Sofdra include:  dry mouth; blurred vision; pain, redness, swelling, itching, and irritation in the underarm area; dilation of the pupils of your eyes; and problems with urination.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Botanix at 1-866-763-6337.

Keep Sofdra and all medicines out of the reach of children.

Please see full Prescribing Information and Patient Product Information.


Print   Email